Group One Trading
PMVP icon

Group One Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Group One Trading’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112 Buy
+90
New +$114 ﹤0.01% 7423
2025
Q3 		– Sell
-7,396
Closed -$10.2K – 8976
2025
Q2 		$7.84K Sell
7,396
-3,900
-35% -$3.83K ﹤0.01% 6870
2025
Q1 		$12.3K Sell
11,296
-3,687
-25% -$5.01K ﹤0.01% 6119
2024
Q4 		$22.6K Sell
14,983
-1,000
-6% -$1.58K ﹤0.01% 5609
2024
Q3 		$23.8K Buy
15,983
+3,133
+24% +$4.84K ﹤0.01% 5141
2024
Q2 		$20.8K Sell
12,850
-3,000
-19% -$5.41K ﹤0.01% 5197
2024
Q1 		$26.9K Buy
15,850
+9,671
+157% +$18.1K ﹤0.01% 5203
2023
Q4 		$19.2K Sell
6,179
-5,659
-48% -$15K ﹤0.01% 5777
2023
Q3 		$72.7K Buy
11,838
+10,819
+1,062% +$74.4K ﹤0.01% 4754
2023
Q2 		$6.38K Buy
1,019
+811
+390% +$4.25K ﹤0.01% 6605
2023
Q1 		$992 Sell
208
-3,474
-94% -$24.4K ﹤0.01% 6789
2022
Q4 		$32K Buy
+3,682
New +$39.2K ﹤0.01% 5295

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Group One Trading's PMVP Position: Q1 2026 in Review

Group One Trading opened a new position in PMV Pharmaceuticals (PMVP) in Q1 2026: 90 shares worth $112. The stake represents ﹤0.01% of the portfolio and ranks #7423 among its holdings. This is a return to the name: Group One Trading previously reported a position in PMVP as recently as Q2 2025.

Group One Trading first reported a position in PMVP in Q4 2022 and has held it in 12 quarters since. The position peaked at $72.7K in Q3 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Group One Trading held 90 shares of PMV Pharmaceuticals worth $112 as of Q1 2026.
  • PMV Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7423 holding.
  • Group One Trading first reported a position in PMV Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
  • Group One Trading's PMV Pharmaceuticals position peaked at $72.7K in Q3 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.